Tag Archive | "Nantpharma"

Sorrento Sells Cynviloq for $1.3B to NantPharma

Tags: ,


Sorrento Therapeutics agreed to sell its drug candidate Cynviloq (paclitaxel nanoparticle polymeric micelle) for up to $1.3 billion to NantPharma.

Read the full story